The Solubility Company Joins the Battle Against COVID-19

The Solubility Company offers free-of-charge solubility measurements for development of therapeutics to combat COVID-19.  “We at The Solubility Company are committed to making our contribution to the global fight against COVID-19. If you are a developer of new small-molecule or peptide therapeutics targeted against COVID-19 and need solubility measurements, please contact us. We will offer free-of-charge solubility measurements for this purpose as much as our capacity allows.

​Our unique SPA Method is particularly well suited for accurate solubility screening from minuscule amounts of solid sample, making it an optimal tool for rapid acquisition of vital solubility data for new drugs.”

-Sami Svanbäck, CEO, The Solubility Company

Share on facebook
Share on linkedin
Share on twitter
Share on email

Recent Posts

The Solubility Company continues its rapid growth and expansion with appointment of a Head of Sales

The Solubility Company and Vironova Medical join forces for anti-viral therapy against COVID-19

SPA™ is a game-changing technology for boosting the drug development process

Leave a Reply

Your email address will not be published. Required fields are marked *